Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...
2d
Pharmaceutical Technology on MSNUK’s pricing watchdog rejects Alzheimer treatments for the second timeThe UK’s National Institute for Health and Care Excellence (NICE) has issued further draft guidance reaffirming its decision ...
"I think it helped," says her husband, Ken Bell. "But I'm not sure." That sort of uncertainty is common when it comes to ...
England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results